BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21177669)

  • 1. Plasmid-encoded OXA-48 carbapenemase in Escherichia coli from Israel.
    Goren MG; Chmelnitsky I; Carmeli Y; Navon-Venezia S
    J Antimicrob Chemother; 2011 Mar; 66(3):672-3. PubMed ID: 21177669
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic utility of boronic acid inhibition with different cephalosporins against Escherichia coli producing AmpC β-lactamases.
    Upadhyay S; Sen MR; Bhattacharjee A
    J Med Microbiol; 2011 May; 60(Pt 5):691-3. PubMed ID: 21292860
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum beta-lactamase associated with the ST131 Escherichia coli clone in Belgium.
    Montesinos I; Rodriguez-Villalobos H; De Mendonça R; Bogaerts P; Deplano A; Glupczynski Y
    J Antimicrob Chemother; 2010 Aug; 65(8):1828-30. PubMed ID: 20534625
    [No Abstract]   [Full Text] [Related]  

  • 4. Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
    Goren MG; Navon-Venezia S; Chmelnitsky I; Carmeli Y
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2687-91. PubMed ID: 20231393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.
    Mantengoli E; Luzzaro F; Pecile P; Cecconi D; Cavallo A; Attala L; Bartoloni A; Rossolini GM
    Clin Infect Dis; 2011 Mar; 52(5):690-1. PubMed ID: 21220769
    [No Abstract]   [Full Text] [Related]  

  • 6. Escherichia coli strains from Kenyan patients carrying conjugatively transferable broad-spectrum β-lactamase, qnr, aac(6')-Ib-cr and 16S rRNA methyltransferase genes.
    Kiiru J; Kariuki S; Goddeeris BM; Revathi G; Maina TW; Ndegwa DW; Muyodi J; Butaye P
    J Antimicrob Chemother; 2011 Jul; 66(7):1639-42. PubMed ID: 21474478
    [No Abstract]   [Full Text] [Related]  

  • 7. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
    Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW
    J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae.
    Bidet P; Burghoffer B; Gautier V; Brahimi N; Mariani-Kurkdjian P; El-Ghoneimi A; Bingen E; Arlet G
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3562-5. PubMed ID: 16048985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of CTX-M-12 extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Bae IK; Lee YN; Hwang HY; Jeong SH; Lee SJ; Kwak HS; Song W; Kim HJ; Youn H
    J Antimicrob Chemother; 2006 Dec; 58(6):1257-9. PubMed ID: 17003059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals.
    Bogaerts P; Rodriguez-Villalobos H; Laurent C; Deplano A; Struelens MJ; Glupczynski Y
    J Antimicrob Chemother; 2009 May; 63(5):1073-5. PubMed ID: 19240070
    [No Abstract]   [Full Text] [Related]  

  • 11. Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum beta-lactamases produced by Klebsiella pneumoniae and Escherichia coli isolated in hospitals in Paraguay.
    Khan MA; Lemmens N; Riera E; Blonk T; Goedhart J; Van Belkum A; Goessens W; Hays JP; Van Westreenen M
    J Antimicrob Chemother; 2009 Dec; 64(6):1330-2. PubMed ID: 19854861
    [No Abstract]   [Full Text] [Related]  

  • 12. High prevalence of extended-spectrum beta-lactamases and plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea.
    Yoo JS; Byeon J; Yang J; Yoo JI; Chung GT; Lee YS
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):261-5. PubMed ID: 20462727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of OXA-244, a chromosomally-encoded OXA-48-like β-lactamase from Escherichia coli.
    Potron A; Poirel L; Dortet L; Nordmann P
    Int J Antimicrob Agents; 2016 Jan; 47(1):102-3. PubMed ID: 26655033
    [No Abstract]   [Full Text] [Related]  

  • 14. Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09).
    Castanheira M; Mendes RE; Woosley LN; Jones RN
    J Antimicrob Chemother; 2011 Jun; 66(6):1409-11. PubMed ID: 21421581
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasmid-mediated quinolone resistance and β-lactamases in Escherichia coli from healthy animals from Nigeria.
    Fortini D; Fashae K; García-Fernández A; Villa L; Carattoli A
    J Antimicrob Chemother; 2011 Jun; 66(6):1269-72. PubMed ID: 21393162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High presence of extended-spectrum beta-lactamases and resistance to quinolones in clinical isolates of Escherichia coli.
    Sorlózano A; Gutiérrez J; de Dios Luna J; Oteo J; Liébana J; Soto MJ; Piédrola G
    Microbiol Res; 2007; 162(4):347-54. PubMed ID: 16564161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of plasmids encoding CMY-2 AmpC beta-lactamases from Escherichia coli in Canadian intensive care units.
    Baudry PJ; Mataseje L; Zhanel GG; Hoban DJ; Mulvey MR
    Diagn Microbiol Infect Dis; 2009 Dec; 65(4):379-83. PubMed ID: 19775846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTX-M-15, OXA-30 and TEM-1-producing Escherichia coli in two Portuguese regions.
    Mendonça N; Louro D; Castro AP; Diogo J; Caniça M
    J Antimicrob Chemother; 2006 May; 57(5):1014-6. PubMed ID: 16531434
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
    Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N
    Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escherichia coli producing KPC-2 carbapenemase: first report in Brazil.
    D'Alincourt Carvalho-Assef AP; Leão RS; da Silva RV; Ferreira AG; Seki LM; Asensi MD; Marques EA
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):337-8. PubMed ID: 20850249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.